SB 1640 authorizes the Missouri Board of Pharmacy to waive compliance with Missouri pharmacy rules and regulations for certain nonprofit pharmacies when they are dispensing, shipping, or delivering prescription drugs into another state or U.S. territory that is experiencing a declared disaster or emergency. The bill defines key terms such as “declared state disaster or emergency,” “disaster period,” and “nonprofit pharmacy,” limiting the bill’s application to licensed Missouri pharmacies that operate as 501(c)(3) charitable organizations.
The waiver authority applies only if the nonprofit pharmacy is in good standing, is authorized to ship into the affected jurisdiction, is responding to an active emergency, complies with the emergency rules of the receiving state or territory, follows all applicable federal law, and delivers only to residents or health care facilities within the disaster area. The bill also allows the Board of Pharmacy to adopt rules to implement the section, while tying those rules to Missouri’s administrative rule review provisions and making the rulemaking authority nonseverable under chapter 536.
Impact
The bill would add a new section to chapter 338, RSMo, giving the Board of Pharmacy explicit authority to suspend or waive otherwise applicable Missouri pharmacy requirements for qualifying nonprofit pharmacies during emergency response efforts outside Missouri. It affects licensed pharmacies, nonprofit charitable pharmacies, the Board of Pharmacy, and recipients in disaster-affected states or territories by easing regulatory barriers for cross-jurisdictional emergency drug distribution. It also creates a new rulemaking framework subject to Missouri’s administrative procedure laws and a sunset-like limitation for rules adopted after August 28, 2026 if certain legislative review powers are invalidated.
Sentiment
Based on the bill text and caption, the measure appears generally supportive of emergency response and charitable pharmacy operations, with a practical focus on enabling rapid access to prescription drugs during disasters. No committee transcripts or recorded votes were provided, so there is no documented opposition or support to assess from legislative debate. The overall tone of the bill is facilitative and narrowly tailored rather than controversial.
Contention
The main potential points of contention are the scope of the Board of Pharmacy’s waiver authority and whether Missouri should relax its pharmacy rules for cross-border dispensing during emergencies. Concerns could include patient safety, oversight of out-of-state distribution, and whether nonprofit pharmacies should receive special regulatory treatment. Supporters would likely emphasize disaster relief, continuity of care, and the limited, emergency-only nature of the waiver, while any critics would likely focus on regulatory consistency and compliance enforcement.